Company / Interest Expense
Incyte Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$2.6M
FY2023
5-year range
$1.9M / $2.7M
FY2019-FY2023
Trend
-4.3%
vs FY2022
Sector context
#36 of 44
Health Care
What the data says
Incyte's interest expense of $3M is lower than 82% of companies in the Health Care sector (FY2023). Interest Expense has fluctuated over the past 8 years, ranging from $2M in FY2020 to $39M in FY2016.
Based on SEC 10-K filings.
$3M in FY2023 with a 5-year CAGR of +10.6%.
Increased from $2M to $3M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +18.2%
- 5-Year CAGR
- +10.6%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 44This company $2.6M Sector average $291.0M
▼
-99.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +10.6%, indicating consistent growth.
- In FY2023, interest expense decreased 4.3% year-over-year.
- Ranks #36 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.7%
- Strong return on equity: 25.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $2.6M | -4.3% |
| FY2022 | $2.7M | +39.7% |
| FY2021 | $1.9M | +23.7% |
| FY2020 | $1.5M | -77.6% |
| FY2019 | $6.9M | +347.2% |
| FY2018 | $1.5M | -77.6% |
| FY2017 | $6.9M | -82.2% |
| FY2016 | $38.7M | -15.0% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026